Kurage

Lyon, FranceFounded 202011–50 employeeskurage.frLinkedIn

Neuromodulation
Neurorehabilitation and assistive tech
Wearables

Kurage develops neurostimulation solutions to support movement rehabilitation and help patients regain mobility and independence. Its NeuroSkin® Class IIa medical device combines functional electrical stimulation, motion sensing, and adaptive analysis for personalized rehabilitation in clinical and home settings.

Visit kurage.fr ↗

Founded: 2020
Employees: 11–50

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Kurage’s product focus is NeuroSkin®, a wearable neurostimulation system designed to support rehabilitation and functional movement. The company’s patent timeline includes two filings dated Sep 16, 2022: “System to determine a personalized profile of stimulation charge rate for a …” and a related international publication. A further patent publication dated Dec 15, 2023 covers a “Device and method for stimulating at least one of a nerve and a muscle of a …”. These filings point to work on tailoring stimulation and delivering nerve or muscle stimulation; they should not be confused with product launch announcements. Kurage’s website describes NeuroSkin as a Class IIa device combining functional electrical stimulation, motion sensing, and adaptive analysis for rehabilitation in clinical and home settings. The system is intended to support activities such as walking, cycling, stair climbing, and sit-to-stand exercises.

Market position

Kurage operates at the intersection of assistive technology, medical devices, digital health, and artificial intelligence. Its NeuroSkin® system differentiates its offering through a combination of functional electrical stimulation, motion and pressure sensing, and adaptive analysis, rather than relying on stimulation alone. The wearable garment and insoles are designed to adjust stimulation to movement patterns and support multiple muscle groups and rehabilitation activities. Connected web and mobile applications add personalized settings and progress monitoring. This places Kurage in the neurorehabilitation and wearable-assistive-device segment, with a stated focus on restoring functional movement and supporting rehabilitation in clinical and home environments. Available company information does not identify named competitors or provide comparative performance, clinical outcome, or market-share data, so a direct competitor ranking would not be reliable. Its listed categories include AI, assistive technology, and software, while its product and website positioning emphasize neurostimulation and rehabilitation. The company’s market distinction is therefore best described by its integrated sensing-and-stimulation approach, not by an unsupported claim of category leadership.

Growth & opportunities

Founded in 2020, Kurage has developed a focused trajectory around AI-supported neuromuscular control and its NeuroSkin® rehabilitation device. Its patent timeline records publications dated Sep 16, 2022 concerning personalized stimulation charge-rate profiles, followed by a nerve or muscle stimulation device publication dated Dec 15, 2023. These dates indicate continuing development of stimulation methods, although patent publications alone do not establish commercial adoption or clinical effectiveness. The company describes NeuroSkin as combining functional electrical stimulation with motion and pressure sensing, adaptive analysis, and connected applications for rehabilitation activities. Overall, the evidence supports a product- and intellectual-property-led development story since 2020, while commercial scale, sales momentum, and financing remain unclear.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Kurage distinct

reccy insights

What makes Kurage distinct

01Combines functional electrical stimulation with continuous motion analysis to adapt stimulation to a user’s movement patterns.
02Uses a lightweight garment and insoles with integrated motion and pressure sensors.
03Designed to activate up to 12 muscle groups and support walking, cycling, stair climbing, and sit-to-stand exercises.
04Connects to web and mobile applications for personalized settings, real-time feedback, and progress monitoring.
05Develops solutions with patients, healthcare professionals, research institutions, APF France Handicap, and the French Red Cross.

Technology & products

NeuroSkin
An AI-driven neuroprosthetic device that stimulates muscles to assist neuromuscular rehabilitation and restore functional movement.

NeuroSkin®: a Class IIa neuromuscular stimulation garment for rehabilitation.
Integrated motion and pressure sensors in the garment and insoles.
Adaptive motion-analysis algorithm that adjusts stimulation patterns.
Electrical stimulation modalities including FES, tSCS, NMES, and TENS.
Connected web and mobile applications for stimulation settings, exercise modes, and progress tracking.

Similar companies

Show all 6 companies

About Kurage

Products: NeuroSkin
Leadership: Amine Metani, Head of Science and Co-FounderRudi Gombauld, President, CEO and Co-Founder
Focus areas: Neurotechnology, medical devices, digital health, therapeutics, neurorehabilitation, functional electrical stimulation, wearable technology
Headquarters: Lyon, France
Founded: 2020
Employees: 11–50
Patents granted: 3 (Crunchbase)
Trademarks: 1